These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3587621)

  • 1. Basal metabolic rate in myotonic dystrophy: evidence against hypometabolism.
    Jozefowicz RF; Welle SL; Nair KS; Kingston WJ; Griggs RC
    Neurology; 1987 Jun; 37(6):1021-5. PubMed ID: 3587621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal metabolic rate in patients with hydrocephalus. On the cause of lowered basal metabolic rate in myotonic dystrophy.
    Hidle I; Sjaastad O
    Acta Neurol Scand; 1976 Mar; 53(3):237-40. PubMed ID: 1266570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myotonic dystrophy: effect of testosterone on total body potassium and on creatinine excretion.
    Griggs RC; Kingston W; Herr BE; Forbes G; Moxley RT
    Neurology; 1985 Jul; 35(7):1035-40. PubMed ID: 4010942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-methylhistidine excretion in myotonic dystrophy.
    Griggs RC; Moxley RT; Forbes GB
    Neurology; 1980 Dec; 30(12):1262-7. PubMed ID: 7192806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of relationship of hypogonadism to muscle wasting in myotonic dystrophy.
    Griggs RC; Kingston W; Herr BE; Forbes G; Moxley RT
    Arch Neurol; 1985 Sep; 42(9):881-5. PubMed ID: 3927876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole body insulin resistance in myotonic dystrophy.
    Moxley RT; Corbett AJ; Minaker KL; Rowe JW
    Ann Neurol; 1984 Feb; 15(2):157-62. PubMed ID: 6367619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo estimation of muscle protein synthesis in myotonic dystrophy.
    Halliday D; Ford GC; Edwards RH; Rennie MJ; Griggs RC
    Ann Neurol; 1985 Jan; 17(1):65-9. PubMed ID: 3985589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forearm 3-methylhistidine efflux in myotonic dystrophy.
    Rifai Z; Kingston WJ; McCraith B; Moxley RT
    Ann Neurol; 1993 Nov; 34(5):682-6. PubMed ID: 8239562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial of testosterone in myotonic dystrophy.
    Griggs RC; Pandya S; Florence JM; Brooke MH; Kingston W; Miller JP; Chutkow J; Herr BE; Moxley RT
    Neurology; 1989 Feb; 39(2 Pt 1):219-22. PubMed ID: 2521699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid metabolism and adrenocortical reactivity to ACTH in myotonic dystrophy.
    Johansson A ; Andrew R; Forsberg H; Cederquist K; Walker BR; Olsson T
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4276-83. PubMed ID: 11549662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased insulin sensitivity of forearm muscle in myotonic dystrophy.
    Moxley RT; Griggs RC; Goldblatt D; VanGelder V; Herr BE; Thiel R
    J Clin Invest; 1978 Oct; 62(4):857-67. PubMed ID: 701484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic studies in muscular dystrophy: a role for insulin.
    Moxley RT
    Adv Neurol; 1977; 17():161-73. PubMed ID: 888734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of testosterone on muscle protein synthesis in myotonic dystrophy.
    Griggs RC; Halliday D; Kingston W; Moxley RT
    Ann Neurol; 1986 Nov; 20(5):590-6. PubMed ID: 2431651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain positron emission tomography in patients with myotonic dystrophy type 1 and type 2.
    Peric S; Brajkovic L; Belanovic B; Ilic V; Salak-Djokic B; Basta I; Rakocevic Stojanovic V
    J Neurol Sci; 2017 Jul; 378():187-192. PubMed ID: 28566162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible role of apamin-sensitive K+ channels in myotonic dystrophy.
    Behrens MI; Jalil P; Serani A; Vergara F; Alvarez O
    Muscle Nerve; 1994 Nov; 17(11):1264-70. PubMed ID: 7935548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. fNIRS evaluation during a phonemic verbal task reveals prefrontal hypometabolism in patients affected by myotonic dystrophy type 1.
    Caliandro P; Silvestri G; Padua L; Bianchi ML; Simbolotti C; Russo G; Masciullo M; Rossini PM
    Clin Neurophysiol; 2013 Nov; 124(11):2269-76. PubMed ID: 23786791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The assessment of muscle mass in progressive neuromuscular disease.
    Griggs RC; Forbes G; Moxley RT; Herr BE
    Neurology; 1983 Feb; 33(2):158-65. PubMed ID: 6681656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intra-abdominal visceral fat in myotonic dystrophy].
    Nozaki S; Miyai I; Kang J
    Rinsho Shinkeigaku; 1992 May; 32(5):521-3. PubMed ID: 1458730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding activity and autophosphorylation of the insulin receptor from patients with myotonic dystrophy.
    Kakehi T; Kuzuya H; Kosaki A; Yamada K; Yoshimasa Y; Okamoto M; Nishimura H; Nishitani H; Saida K; Kuno S
    J Lab Clin Med; 1990 Jun; 115(6):688-95. PubMed ID: 2195130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The direct relationship of proinsulin-insulin hypersecretion to basal serum levels of cholesterol and triglyceride in myotonic dystrophy.
    Poffenbarger PL; Bozefsky T; Soeldner JS
    J Lab Clin Med; 1976 Mar; 87(3):384-96. PubMed ID: 765416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.